MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Neurophysiology"

  • 2022 International Congress

    Perceive: A data extraction and analysis toolbox for brain signals from sensing enabled deep brain stimulators

    WJ. Neumann (Berlin, Germany)

    Objective: Develop an open source toolbox that facilitates data extraction, analysis, artifact correction and standardization for the DBS research community. Background: Novel sensing enabled implantable…
  • 2022 International Congress

    Parkinson’s disease symptom asymmetry at disease onset corresponds to low-beta power asymmetry in the subthalamic nucleus

    A. Buijink, F. Torrecillos, M. Stam, D. Piña-Fuentes, A. Pogosyan, C. Wiest, R. de Bie, P. Schuurman, G. Tinkhauser, H. Tan, M. Beudel (Amsterdam, Netherlands)

    Objective: Compare beta-power in the subthalamic nucleus (STN) between the most affected and least affected body side at disease onset. Background: Exaggerated beta activity (13–35…
  • 2022 International Congress

    At-home prolonged adaptive deep brain stimulation improves symptoms and reduces side effects in Parkinson’s disease

    C. Oehrn, S. Cernera, L. Hammer, M. Shcherbakova, A. Hahn, R. Gilron, C. Smyth, R. Wilt, S. Little, P. Starr (SAN FRANCISCO, USA)

    Objective: Objective: To assess the effect of at-home adaptive deep brain stimulation (aDBS) on symptoms and treatment-associated side-effects in one patient with Parkinson’s disease (PD),…
  • 2022 International Congress

    Personalization of deep brain stimulation using local field potentials to drive adaptive DBS: a case series

    H. Kamo, G. Oyama, T. Brionne, D. Kamiyama, A. Umemura, H. Iwamuro, A. Bovet, G. Spriano, A. Singer, P. Di Stefano, N. Hattori (Tokyo, Japan)

    Objective: To observe chronically recorded local field potentials (LFPs) in patients receiving Deep Brain Stimulation (DBS) for Parkinson’s Disease (PD) and using an adaptive DBS…
  • 2022 International Congress

    Local Field Potential from Subthalamic Nucleus Correlate with Attentional Performance in Parkinson’s Disease

    MS. Rocha, A. Fim Neto, B. Bianqueti, J. de Luccas, D. Soriano, L. da Silva, F. Godinho (SAO PAULO, Brazil)

    Objective: To investigate a correlation between the subthalamic nucleus (STN) local field potentials (LFP) and attentional performance in Parkinson's disease (PD) patients. Background: Attentional deficits…
  • 2022 International Congress

    Epileptic seizures in patients with parkinsonism: experience of a tertiary centre

    C. Azoia, R. Jesus, A. Costa, A. Velon, P. Guimarães (Vila Real, Portugal)

    Objective: We aim to evaluate seizure frequency in patients with parkinsonism in a tertiary centre. Background: Observational studies suggest that the prevalence of epilepsy in…
  • 2022 International Congress

    Investigative Study of Local Field Potential (LFP) changes during acute and chronic Deep Brain Stimulation (DBS) in Parkinson’s Disease (PD) patients

    G. Varga, V. Rayudu, J. Abraham (Austin, USA)

    Objective: We aimed to investigate LFP changes during acute and chronic DBS in Parkinson’s Disease (PD) patients. Our study implies neuroplastic changes during stimulation, and…
  • 2022 International Congress

    Exploring the impact of central cholinergic dysfunction on cognitive functioning in patients of Parkinson’s disease with and without REM sleep behavior disorder

    A. Bhattacharya, K. Udupa, N. Kamble, M. Gothwal, S. Hegde, R. Yadav, PK. Pal (Bengaluru, India)

    Objective: This paper aims at establishes the presence of significantly higher cholinergic dysfunction in patients using short latency afferent inhibition. Background: Parkinson's disease (PD) is…
  • 2022 International Congress

    HAB-C murine model present reactive adult neurogenesis and astrogliosis in adult brain

    V. Hernandez, A. Juarez, D. Carmona (Leon, Mexico)

    Objective: To analyze the adult neurogenic response to a neurodegenerative process due to H-ABC tubulinopathy. Background: H-ABC is a neurodegenerative disease caused by mutations in…
  • 2022 International Congress

    Relationship between cholinergic basal forebrain volume and short-latency sensory afferent inhibition in Parkinson’s disease with varying degrees of cognitive performance

    JF. Martín-Rodríguez, P. Franco Rosado, E. Iglesias Camacho, AM. Castellano-Gerrero, MA. Labrador-Espinosa, B. Villarreal, L. Muñoz-Delgado, D. Macías-García, P. álvarez Toledo, M. San Eufrasio, M. Reina Castillo, S. Jesús, A. Adarmes-Gómez, F. Carrillo, MJ. Grothe, P. Mir (Sevilla, Spain)

    Objective: To assess the relationship between volumetric measures of cholinergic basal forebrain (CBF) degeneration and short-latency sensory afferent inhibition (SAI) in Parkinson’s disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 28
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley